COVID-19 Infection Shown to Significantly Increase Drug Clearance of Therapeutic Monoclonal Antibodies

Patients with inflammatory diseases being treated with therapeutic monoclonal antibodies (mAbs) such as Infliximab may experience a significant increase in...

March 30, 2023 | Thursday | News
Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies

ArsenalBio recently advanced its lead product candidate into clinical manufacturing of its autologous integrated circuit T cell (ICT) therapy for...

March 29, 2023 | Wednesday | News
TandemAI launches TandemViz™ 1.0 - a web-based GUI for integrated computational analysis and experimental data

TandemAI today announced the release of TandemViz™ 1.0, the company’s proprietary web-based platform that provides its growing roster of drug d...

March 29, 2023 | Wednesday | News
Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board

Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potenti...

March 28, 2023 | Tuesday | News
Women Leaders Coming Together for Fourth Annual Medtech Conference

 Registration is open for women in the life sciences industry to join the fourth MedExecWomen Annual Conference, Growing Your Business, Yourself,...

March 28, 2023 | Tuesday | News
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | Tuesday | News
Vertex and CRISPR Therapeutics Team Up for Hypoimmune Cell Therapy Development for Type 1 Diabetes

Vertex to receive non-exclusive rights to CRISPR Therapeutics’ CRISPR/Cas9 to accelerate development of potentially curative cell therapies for T1D- ...

March 28, 2023 | Tuesday | News
Merck KGaA Secures Exclusive Worldwide Rights to BAVENCIO® (avelumab)

Merck KGaA, Darmstadt, Germany regains exclusive worldwide rights to develop, manufacture and commercialize BAVENCIO from Pfizer Deal is the latest exam...

March 28, 2023 | Tuesday | News
Teva's Collaboration with Rimidi Expands to Integrate Respiratory Monitoring with US Health System

California’s Desert Oasis Healthcare (DOHC) implements Rimidi’s Respiratory Module for respiratory patient monitoring, based on data collecte...

March 28, 2023 | Tuesday | News
Testosterone Pellet Therapy Boosts Bone Density in Males: Study

In a case study, a 54-year-old male patient with a spontaneous fracture and osteoporosis achieved an “almost complete recovery of osteoporosis”...

March 28, 2023 | Tuesday | News
Exactech Boosts AI Capabilities with Exclusive Machine-Learning Software Licensing Agreement and Data Scientist Team

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today it has ex...

March 28, 2023 | Tuesday | News
New InnoGenomics Technology Revolutionizes DNA Testing of Sexual Assault Samples

Addressing a long-term shortcoming in DNA evidence for rape and sexual assault cases, New Orleans-based InnoGenomics has developed a nanotech method, Sperm...

March 28, 2023 | Tuesday | News
ABL appoints Stéphanie Colloud as general manager and chief operating officer to lead European activities

ABL, a pure play Contract Development and Manufacturing Organization (CDMO) with specialized expertise in the development and manufacturing of solutions fo...

March 27, 2023 | Monday | News
Waters Corp introduces next-generation Alliance iS HPLC system

US-headquartered Waters Corporation has introduced Alliance iS , the next-generation intelligent HPLC system designed to reduce compliance risk b...

March 26, 2023 | Sunday | Product Spotlight

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close